Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Gavreto 100 mg hard capsules {equilateral_black_triangle}

Discontinued
Active Ingredient:
pralsetinib
Company:  
Roche Products Limited See contact details
ATC code: 
L01EX23
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Product Information HCP Med Info
{arrow_left}
{arrow_right}
{healthcare_pro_orange} For Healthcare Professionals

IMPORTANT INFORMATION:

Please note that Gavreto was divested to Blueprint Medicines on 27 September 2024 and then discontinued by the new owner.

Roche Products Limited
Company image
Address
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone
+44 (0)1707 366 000
Fax
+44 (0)1707 338 297
Medical Information Direct Line
+44 (0)800 328 1629
Customer Care direct line
+44 (0)800 731 5711
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0)1707 384555
WWW
http://www.roche.co.uk